Pharmaceuticals Projects in Rajasthan – Page 2

14 upcoming and ongoing pharmaceuticals projects in Rajasthan worth ₹588 Cr, with investment, location, project stage and latest status. Last updated 17 Jun 2026.

Projects tracked
14
Total investment
₹588 Cr
Pre-project / Under construction
0 / 0
Added in the last 30 days
0

Latest pharmaceuticals projects in Rajasthan

Showing 6–10 of 14
  1. Under Implementation Pharmaceuticals Projects Updated

    Active Pharmaceuticals Ingredients Mfg. Expansion Project in Kota, Rajasthan

    Rajasthan Less than 100 Million

    A pharmaceutical company plans to expand its active pharmaceutical ingredients (API) manufacturing in Kota, Rajasthan. The project aims to increase the manufacturing capacity from 480 TPA to 5,002.2 TPA. The estimated project cost is Rs. 80.143 million. Construction begins in February 2024, ends in February 2024, pending environmental clearance.

    View project
  2. Pre Project Stage Pharmaceuticals Projects Updated

    Rs.3000 Million New Fertility Hormone Mfg. Facility in Udaipur, Rajasthan

    Rajasthan From 1000 Million to 4999 Million

    A new fertility hormone manufacturing facility is planned to be set up in Udaipur, Rajasthan. The project aims to manufacture the drug used for preventing miscarriage and treating infertility. The project is estimated to cost Rs.3000 million and has received consent from state pollution control authorities in April 2023.

    View project
  3. Under Implementation Pharmaceuticals Projects Updated

    Rs.195 Million Pharmaceutical Mfg. Unit in Jaipur, Rajasthan

    Rajasthan From 100 Million to 999 Million

    A Company is planning to take up Pharmaceutical manufacturing unit in Jaipur, Rajasthan. The project involves manufacturing of pharmaceutical products (EC product) of capacity 21833.41 TPA, Etc.

    View project
  4. Pre Project Stage Pharmaceuticals Projects Updated

    New Solifenacin- Sachets Mfg. Plant in Rangareddy, Telangana

    Rajasthan More than 49999 Million

    A global biopharmaceutical company has filed an industrial entrepreneurs' memorandum for a new manufacturing plant in Rangareddy, Telangana, to produce solifenacin-sachets for treating overactive bladder in adults. The plant is expected to have a manufacturing capacity of 1314256 Nos. The company has a strong presence in India, with a focus on reproductive medicine and maternal health, and is committed to sustainability.

    View project